JBM (Healthcare) Limited (HKG:2161)

Market Cap	1.95B +7.6%
Revenue (ttm)	812.98M +12.8%
Net Income	216.39M +32.0%
EPS	0.25 +26.4%
Shares Out	817.30M
PE Ratio	9.71
Forward PE	9.12
Dividend	0.20 (8.16%)
Ex-Dividend Date	n/a

Volume	86,000
Open	2.400
Previous Close	2.390
Day's Range	2.360 - 2.400
52-Week Range	2.350 - 3.430
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 12, 2026

About JBM (Healthcare)

JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and distributes...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2020
• Employees: 412
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2161

Financial Performance

In fiscal year 2025, JBM (Healthcare)'s revenue was 782.29 million, an increase of 20.65% compared to the previous year's 648.42 million. Earnings were 197.26 million, an increase of 51.20%.